Evidence map›Paper›PMID 40898804›Full record

ArticleThe Australasian journal of dermatology2025

The Use of Etanercept in the Palliative Treatment of a Patient With Generalised Bullous Fixed Drug Eruption.

Olga Pawlik, Timothy Cowan, Andrew Miller

Abstract readCase Reports
In one paragraph

Article in The Australasian journal of dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Olga PawlikDepartment of Dermatology, The Canberra Hospital, Canberra Health Services, ACT, Canberra, Australia.ORCID https://orcid.org/0000-0002-2654-6373
Timothy CowanDepartment of Dermatology, The Canberra Hospital, Canberra Health Services, ACT, Canberra, Australia.ORCID https://orcid.org/0000-0003-1212-269X
Andrew MillerDepartment of Dermatology, The Canberra Hospital, Canberra Health Services, ACT, Canberra, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Generalised Bullous Fixed Drug Eruption (GBFDE) is a subtype of Fixed Drug Eruption (FDE) characterised by the development of generalised blisters on the background of dusky macules. There is no gold standard treatment, but the condition is conventionally managed with supportive care, topical and oral steroids and occasionally ciclosporin. We describe the case of a 75-year-old female with GBFDE, who demonstrated a rapid halt in disease progression and re-epithelialisation following a single dose of etanercept. This case highlights the potential role of etanercept in the management of GBFDE.

Indexed as

Drug EruptionsEtanerceptPalliative CareSkin Diseases, VesiculobullousAgedFemaleHumansEtanercept

Identifiers

PMID40898804
PMCPMC12633692

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.